EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Galectin-3 Binds to the Allosteric Site and Activates Integrins αvβ3, αIIbβ3, and α5β1, and Lactose Inhibits This Activation

Yoko K Takada, Yu-Jui Yvonne Wan, Yoshikazu Takada iD

Biomolecules · 15.04.2026 · 16 (4) · 586

DOI: 10.3390/biom16040586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 15.04.2026. Verfasst von Yoko K Takada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of California Davis, 4645 Second Avenue, Sacramento, CA 95817, USA. Hauptthemen laut MEDLINE: Galectin 3, Integrin alphaVbeta3, Lactose, Integrin alpha5beta1. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UC Davis Comprehensive Cancer Center Support Grant (CCSG), NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Galectin-3 (Gal3) is one of the most pro-inflammatory proteins and a biomarker of inflammatory diseases and cancer. Previous studies showed that Gal3 binds to αv and β1 integrins, but it is unclear how Gal3 binds to integrins. Here, we show that Gal3 bound to soluble αvβ3 and αIIbβ3 integrins in 1 mM Mn2+ in cell-free conditions in a glycan-independent manner. Docking simulation predicts that Gal3 binds to the classical RGD-binding site (site 1) of αvβ3, but the predicted Gal3-binding site does not include galactose-binding site. RGDfV or eptifibatide inhibited Gal3 binding to αvβ3 and αIIbβ3, respectively, but lactose, a pan-galectin inhibitor, did not inhibit Gal3 binding to integrins. Point mutations of the predicted site 1 binding interface of Gal3 effectively inhibited Gal3 binding to site 1. Site 2 is involved in pro-inflammatory signaling (e.g., TNF and IL-6 secretion), and we previously showed that pro-inflammatory cytokines (e.g., CCL5 and TNF) bind to site 2 and allosteric integrin activation. Docking simulation predicted that Gal3 binds to site 2 of αvβ3 and α5β1. We found that Gal3 induced allosteric activation of soluble integrins αvβ3, αIIbβ3, and α5β1 in 1 mM Ca2+ in cell-free conditions. Point mutations in the predicted site 2 binding interface inhibited Gal3-induced integrin activation, suggesting that Gal3 binding to site 2 is required for Gal3-induced integrin activation. Known anti-inflammatory agents, Ivermectin, NRG1, and FGF1, inhibited integrin activation induced by Gal3 in αvβ3 and αIIbβ3. These findings suggest that Gal3 binding to site 2 may be a potential mechanism of pro-inflammatory and pro-thrombotic action of Gal3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Galectin 3Integrin alphaVbeta3LactoseIntegrin alpha5beta1Platelet Glycoprotein GPIIb-IIIa ComplexHumansAllosteric SiteProtein BindingMolecular Docking SimulationBinding Sites

Stichwörter der Autor:innen

allosteric sitegalectin-3integrin activationpro-inflammatory actionpro-thrombotic action

Substanzen

Galectin 3Integrin alphaVbeta3LactoseIntegrin alpha5beta1Platelet Glycoprotein GPIIb-IIIa Complex

Autor:innen und Institutionen

  • Department of Dermatology, School of Medicine, University of California Davis, 4645 Second Avenue, Sacramento, CA 95817, USA.
  • Department of Pathology, School of Medicine, University of California Davis, 4645 Second Avenue, Sacramento, CA 95817, USA.
  • Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, 4645 Second Avenue, Sacramento, CA 95817, USA.

ORCID-Profile: Yoshikazu Takada

Förderung

  • UC Davis Comprehensive Cancer Center Support Grant (CCSG)
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Takada, Y. K., Wan, Y. Y., & Takada, Y. (2026). Galectin-3 Binds to the Allosteric Site and Activates Integrins αvβ3, αIIbβ3, and α5β1, and Lactose Inhibits This Activation. Biomolecules, 16(4), 586. https://doi.org/10.3390/biom16040586

Vancouver

Takada YK, Wan YY, Takada Y. Galectin-3 Binds to the Allosteric Site and Activates Integrins αvβ3, αIIbβ3, and α5β1, and Lactose Inhibits This Activation. Biomolecules. 2026;16(4):586. doi:10.3390/biom16040586

BibTeX
@article{Takada2026,
  author = {Takada, Yoko K and Wan, Yu-Jui Yvonne and Takada, Yoshikazu},
  title = {Galectin-3 Binds to the Allosteric Site and Activates Integrins αvβ3, αIIbβ3, and α5β1, and Lactose Inhibits This Activation},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {586},
  doi = {10.3390/biom16040586}
}
Kostenlos starten →